ITM Obtains Manufacturing License in the U.S.
February 01, 2024 07:00 ET
|
ITM Isotope Technologies Munich SE
License will support ITM’s efforts in preparing for the commercialization of its diagnostic and therapeutic radiopharmaceutical pipeline across the U.S. Garching / Munich and...
ITM Appoints Dr. Mark Harfensteller as Member of its Executive Board
January 16, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, January 16, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the appointment of Dr. Mark Harfensteller to its...
Radiopharmaceuticals Market Size Worth USD 14.45 Billion in 2032 | Emergen Research
January 15, 2024 08:00 ET
|
Emergen Research
Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global radiopharmaceuticals market size was USD 5.30 Billion in 2022 and is expected to register a rapid revenue CAGR of 10.6% during the forecast...
QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee
November 14, 2023 07:30 ET
|
QSAM Biosciences Inc.
Austin, TX, Nov. 14, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing therapeutic radiopharmaceuticals for the treatment of primary and secondary bone cancer and...
Nuclear Medicine Market to Hit USD 25 Mn | Innovations and Insights into Diagnostic Advancements (2023-2032)
September 15, 2023 06:25 ET
|
Market.Us
New York, Sept. 15, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Nuclear Medicine Market size is expected to be worth around USD 25 Million by 2032 from USD 7.0...
ITM to Host Theranostics Symposium on Clinical Need and Supply at SNMMI Annual Meeting on Sunday, June 25, 2023
June 15, 2023 04:23 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, June 15, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a multidisciplinary symposium titled,...
ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities
June 05, 2023 05:00 ET
|
ITM Isotope Technologies Munich SE
One of the largest private investment rounds in European biotech to-dateNet proceeds will enhance ITM’s radiopharmaceutical pipeline, bolster commercial infrastructure, expand leading...
Global Radiopharmaceuticals Market Size & Share to Surpass $9.75 Billion by 2030 | Vantage Market Research
May 24, 2023 10:20 ET
|
Vantage Market Research
WASHINGTON, May 24, 2023 (GLOBE NEWSWIRE) -- The Global Radiopharmaceuticals Market is valued at USD 5.2 Billion in 2022 and is projected to reach a value of USD 9.75 Billion by 2030 at a CAGR...
Novel Workflow Approaches Create Significant Opportunities in Radiopharmaceuticals Market, as per TMR Study
May 15, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 15, 2023 (GLOBE NEWSWIRE) -- According to TMR market research, the global radiopharmaceuticals industry growth is expected to be robust owing to rise in...
ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer
April 27, 2023 05:00 ET
|
ITM Isotope Technologies Munich SE
Enhancement of ITM’s development and manufacturing activities strengthens ITM’s position as a pioneer and leader in Targeted Radionuclide Therapy (TRT) Garching / Munich, April 27, 2023 – ITM...